TickerFacts.

Company research / HCM

HUTCHMED (China) Ltd (HCM)

Also trades as HMDCF. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001648257 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing

For the year ended 2025-12-31, HUTCHMED (China) Ltd reported revenue of $548.51M. Revenue fell 13.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

38.7%
Gross margin (computed)
-7.1%
Operating margin
83.3%
Net margin
36.5%
Return on year-end equity
-13.0%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-29

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$548.51M$630.20M$838.00M$426.41M$356.13M$227.98M$204.89M$214.11M$241.20M$216.08M
Cost of Revenue$336.35M$348.88M$384.45M$311.10Mn/an/an/an/an/an/a
Gross Profit (computed)$212.16M$281.32M$453.55M$115.31Mn/an/an/an/an/an/a
R&D Expense$148.29M$212.11M$302.00M$386.89M$299.09M$174.78M$138.19M$114.16M$75.52M$66.87M
Operating Income-$39.16M-$43.70M$18.38M-$407.69M-$328.32M-$196.67M-$146.39M-$92.64M-$53.42M-$46.70M
Depreciation & Amortization$13.31M$12.34M$8.21M$8.66M$7.19M$6.06M$4.94M$3.59M$2.58M$2.34M
EBITDA-$25.85M-$31.36M$26.58M-$399.03M-$321.13M-$190.61M-$141.44M-$89.05M-$50.84M-$44.36M
Net Income$456.91M$37.73M$100.78M-$360.83M-$194.65M-$125.73M-$106.02M-$74.81M-$26.74M$11.70M
EPS (Diluted)$0.52$0.04$0.12-$0.43-$0.25-$0.18-$0.16-$1.13-$0.43$0.20
Total Assets$1.75B$1.27B$1.28B$1.03B$1.37B$724.12M$465.12M$532.12M$597.93M$342.44M
Total Liabilities$501.83M$502.34M$536.39M$392.57M$333.15M$205.17M$152.22M$119.86M$112.97M$138.38M
Long-Term Debt$93.16M$82.81M$79.34M$18.10Mn/an/an/a$26.74M$29.99M$46.79M
Shareholders' Equity$1.25B$771.85M$743.39M$636.87M$1.04B$518.95M$312.90M$412.25M$484.97M$204.06M
Cash & Equivalents$71.33M$153.96M$283.59M$313.28M$377.54M$235.63M$121.16M$86.04M$85.27M$79.43M
Operating Cash Flow-$64.66M$497.0K$219.26M-$268.60M-$204.22M-$62.07M-$80.91M-$32.85M-$8.94M-$9.57M
Capital Expenditures$14.15M$17.93M$32.61M$36.66M$16.40M$7.95M$8.56M$6.36M$5.02M$4.33M
Free Cash Flow-$78.81M-$17.44M$186.65M-$305.26M-$220.62M-$70.02M-$89.48M-$39.21M-$13.96M-$13.90M
Share Repurchasesn/a$36.06M$9.07M$48.08M$27.31M$12.90M$346.0K$5.45M$1.37M$604.0K
Weighted Average Diluted Shares872.89M872.83M869.20M847.14M792.68M697.93M665.68M66.43M61.72M59.97M
EPS (Basic)$0.53$0.04$0.12-$0.43-$0.25-$0.18-$0.16-$0.11-$0.04$0.20

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView